Monday, September 23, 2019

USFDA issues 1 observation for Karakhadi unit of Aleor Dermaceuticals

USFDA issues 1 observation for Karakhadi unit of Aleor Dermaceuticals The United States Food and Drug Administration (USFDA) carried out the inspection of Aleor Dermaceuticals#39; formulation manufacturing facility at Karakhadi in Gujarat from September 15-20, 2019, it added.

from Moneycontrol Business News https://ift.tt/2QnzeFm
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...